(Q38747875)

English

Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical Outcomes

scientific article published on 9 March 2017

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

Pooled Clustering of High-Grade Serous Ovarian Cancer Gene Expression Leads to Novel Consensus Subtypes Associated with Survival and Surgical Outcomes (English)

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

1 reference

based on heuristic

inferred from title

10

object named as

Ellen L Goode

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

Kimberly R Kalli

3

object named as

Kimberly R Kalli

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

Sebastian M Armasu

2

object named as

Sebastian M Armasu

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

Matthew J. Maurer

4

object named as

Matthew J Maurer

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

8

object named as

Ann L Oberg

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

Scott H Kaufmann

9

object named as

Scott H Kaufmann

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

William A Cliby

7

object named as

William A Cliby

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

6

object named as

Gary L Keeney

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

author name string

Chen Wang

1

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

Ethan P Heinzen

5

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

language of work or name

0 references

publication date

9 March 2017

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

Clinical Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

23

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

15

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

4077-4085

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three Subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Cancer statistics, 2016

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Clinical implications of the intrinsic molecular subtypes of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

A framework for a personalized surgical approach to ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Prognostic and therapeutic relevance of molecular subtypes in high-grade serous ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

The MyD88+ phenotype is an adverse prognostic factor in epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Molecular biomarkers of residual disease after surgical debulking of high-grade serous ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Tumor mutation burden forecasts outcome in ovarian cancer with BRCA1 or BRCA2 mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

A collagen-remodeling gene signature regulated by TGF-β signaling is associated with metastasis and poor survival in serous ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

TGF-β modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Inherited variants in regulatory T cell genes and outcome of ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

GSVA: gene set variation analysis for microarray and RNA-seq data.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

How many molecular subtypes? Implications of the unique tumor principle in personalized medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Strategies for aggregating gene expression data: the collapseRows R function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Integrated genomic analyses of ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Regularization Paths for Generalized Linear Models via Coordinate Descent

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

GAGE: generally applicable gene set enrichment for pathway analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Defining the cut point between low-grade and high-grade ovarian serous carcinomas: a clinicopathologic and molecular genetic analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Supervised risk predictor of breast cancer based on intrinsic subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Adjusting batch effects in microarray expression data using empirical Bayes methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Cancer of the ovary

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Metagenes and molecular pattern discovery using matrix factorization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Statistical significance for genomewide studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

23 June 2018

Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

31 August 2018

Whole-genome characterization of chemoresistant ovarian cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

31 August 2018

Efficient molecular subtype classification of high-grade serous ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

31 August 2018

POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

31 August 2018

Molecular Subtypes of High-Grade Serous Ovarian Cancer: The Holy Grail?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567822

3 December 2018

Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/28280090

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/28280090

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-17-0246

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 March 2018

http://europepmc.org/abstract/PMC/5567822

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38747875&oldid=1858285028"